Nareg Sagherian | Executive Director, Investor Relations |
Jerry Durso | President and Chief Executive Officer |
Linda Richardson | Chief Commercial Officer |
Dr. Michelle Berrey | President, Research & Development and Chief Medical Officer |
Andrew Saik | Chief Financial Officer |
Ritu Baral | Cowen |
Mayank Mamtani | B. Riley Securities |
Jon Wolleben | JMP Securities |
Joseph Stringer | Needham & Company |
Brian Skorney | Baird |
Brian Abrams | RBC Capital Markets |
Jay Olson | Oppenheimer |
Eliana Merle | UBS |
Good day and thank you for standing by. Welcome to the Intercept Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.